BTC Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

BTC Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5M	Sell	43,653 -81	-0.2%	-$17.7K	0.64%	47
2026 Q1	$8.27M	Sell	43,734 -3,814	-8%	-$667K	0.56%	47
2025 Q4	$8.09M	Sell	47,548 -4,173	-8%	-$640K	0.56%	47
2025 Q3	$6.82M	Buy	51,721 +1,243	+2%	+$149K	0.47%	57
2025 Q2	$5.33M	Buy	50,478 +1,125	+2%	+$122K	0.44%	71
2025 Q1	$6.13M	Sell	49,353 -300	-0.6%	-$39.1K	0.56%	56
2024 Q4	$6.11M	Buy	49,653 +4,271	+9%	+$503K	0.57%	58
2024 Q3	$5.06M	Buy	+45,382	New	+$4.97M	0.45%	69

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BTC Capital Management's JAZZ Position: Q2 2026 in Review

BTC Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.19% in Q2 2026, selling an estimated $17.7K and leaving 43,653 shares worth $10.5M. The position accounts for 0.64% of the portfolio, ranked #47.

BTC Capital Management first reported a position in JAZZ in Q3 2024 and has held it in 8 quarters since. 238 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

BTC Capital Management held 43,653 shares of Jazz Pharmaceuticals worth $10.5M as of Q2 2026.
BTC Capital Management sold 81 Jazz Pharmaceuticals shares in Q2 2026, an estimated $17.7K.
Jazz Pharmaceuticals made up 0.64% of BTC Capital Management's portfolio in Q2 2026, its #47 holding.
BTC Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
238 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on BTC Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.